220 related articles for article (PubMed ID: 10925366)
1. In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.
Mitjans F; Meyer T; Fittschen C; Goodman S; Jonczyk A; Marshall JF; Reyes G; Piulats J
Int J Cancer; 2000 Sep; 87(5):716-23. PubMed ID: 10925366
[TBL] [Abstract][Full Text] [Related]
2. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
[TBL] [Abstract][Full Text] [Related]
3. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
[TBL] [Abstract][Full Text] [Related]
4. An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice.
Mitjans F; Sander D; Adán J; Sutter A; Martinez JM; Jäggle CS; Moyano JM; Kreysch HG; Piulats J; Goodman SL
J Cell Sci; 1995 Aug; 108 ( Pt 8)():2825-38. PubMed ID: 7593323
[TBL] [Abstract][Full Text] [Related]
5. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
[TBL] [Abstract][Full Text] [Related]
7. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.
Nisato RE; Tille JC; Jonczyk A; Goodman SL; Pepper MS
Angiogenesis; 2003; 6(2):105-19. PubMed ID: 14739617
[TBL] [Abstract][Full Text] [Related]
8. IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.
Bello L; Lucini V; Giussani C; Carrabba G; Pluderi M; Scaglione F; Tomei G; Villani R; Black PM; Bikfalvi A; Carroll RS
Neurosurgery; 2003 Jan; 52(1):177-85; discussion 185-6. PubMed ID: 12493116
[TBL] [Abstract][Full Text] [Related]
9. alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin.
Taga T; Suzuki A; Gonzalez-Gomez I; Gilles FH; Stins M; Shimada H; Barsky L; Weinberg KI; Laug WE
Int J Cancer; 2002 Apr; 98(5):690-7. PubMed ID: 11920637
[TBL] [Abstract][Full Text] [Related]
10. Alphavbeta5-integrins mediate early steps of metastasis formation.
Enns A; Korb T; Schlüter K; Gassmann P; Spiegel HU; Senninger N; Mitjans F; Haier J
Eur J Cancer; 2005 May; 41(7):1065-72. PubMed ID: 15862757
[TBL] [Abstract][Full Text] [Related]
11. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
12. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
Li L; Wartchow CA; Danthi SN; Shen Z; Dechene N; Pease J; Choi HS; Doede T; Chu P; Ning S; Lee DY; Bednarski MD; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1215-27. PubMed ID: 15001266
[TBL] [Abstract][Full Text] [Related]
13. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis.
Kang IC; Kim DS; Jang Y; Chung KH
Biochem Biophys Res Commun; 2000 Aug; 275(1):169-73. PubMed ID: 10944460
[TBL] [Abstract][Full Text] [Related]
14. Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins.
Goodman SL; Hölzemann G; Sulyok GA; Kessler H
J Med Chem; 2002 Feb; 45(5):1045-51. PubMed ID: 11855984
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6.
Lehmann M; Rabenandrasana C; Tamura R; Lissitzky JC; Quaranta V; Pichon J; Marvaldi J
Cancer Res; 1994 Apr; 54(8):2102-7. PubMed ID: 7513610
[TBL] [Abstract][Full Text] [Related]
16. Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors.
Triantafilou K; Triantafilou M; Takada Y; Fernandez N
J Virol; 2000 Jul; 74(13):5856-62. PubMed ID: 10846065
[TBL] [Abstract][Full Text] [Related]
17. Effects of the novel alphav integrin antagonist SM256 and cis-platinum on growth of murine squamous cell carcinoma PAM LY8.
Van Waes C; Enamorado-Ayala I; Hecht D; Sulica L; Chen Z; Batt DG; Mousa S
Int J Oncol; 2000 Jun; 16(6):1189-95. PubMed ID: 10811994
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of alphav integrins in K1735 melanoma cells.
Li X; Chen B; Blystone SD; McHugh KP; Ross FP; Ramos DM
Invasion Metastasis; 1998; 18(1):1-14. PubMed ID: 10207246
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of salmosin, a Korean snake venom-derived disintegrin, on the integrin alphav-mediated proliferation of SK-Mel-2 human melanoma cells.
Chung KH; Kim SH; Han KY; Sohn YD; Chang SI; Baek KH; Jang Y; Kim DS; Kang IC
J Pharm Pharmacol; 2003 Nov; 55(11):1577-82. PubMed ID: 14713370
[TBL] [Abstract][Full Text] [Related]
20. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
van der Horst G; Bos L; van der Mark M; Cheung H; Heckmann B; Clément-Lacroix P; Lorenzon G; Pelger RC; Bevers RF; van der Pluijm G
PLoS One; 2014; 9(9):e108464. PubMed ID: 25247809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
